Latest / Green Bay News Today | 2 Min News | The Daily News Now!
Mounjaro Gets Broader Approval | Green Bay News
FDA just approved Mounjaro for more adults with type two diabetes at higher risk — and it’s a game-changer. Eli Lilly’s drug slashes major heart events by 8% compared to its older version, Trulicity, and shares the same active ingredient as the weight-loss drug Zepbound. Trials showed equal effectiveness in men and women, though GI side effects are possible. With a potential $1,300 price tag without insurance (or as low as $25 with savings cards), this approval opens new doors for patients — and Eli Lilly isn’t stopping there, already testing next-gen hormone-targeting drugs. Listen in…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.